A new study has shown that U.S. heart attack victims are becoming both younger and fatter. According to researchers from the Cleveland Clinic, the average age of people who suffer from deadly heart attacks dropped from 64 to 60 over the last … Read More
MONDAY, April 18, 2016 (HealthDay News) — Metformin, the most frequently prescribed standalone drug for type 2 diabetes, is better for the heart than its closest competitors, a large analysis suggests.
Metformin reduced the risk … Read More
British researchers from the University of York have recently found that lonely people living in isolation could face a heightened risk of heart disease and stroke. These findings came from analyzing previously published studies that included… Read More
A Paleo diet could help older women to lower their risk of developing heart disease and diabetes while also losing weight. The study followed 35 obese, postmenopausal women who had normal blood sugar levels and were asked to follow a Paleo diet… Read More
The British Medical Journal recently published data from a 40-year-old study that looked at the connection between heart health and dietary fats. The findings directly contradicted some widely accepted nutritional information, and had… Read More
A new study has shown that taking long naps during the day is associated with an increased risk for metabolic syndrome, which can also boost your risk of type 2 diabetes and heart disease. Metabolic syndrome includes conditions like high blood… Read More
A recent analysis found that type 2 diabetes treatment using incretin-based therapies was not associated with an increased risk of heart failure. Canadian researchers came to this conclusion after studying a cohort of nearly 1.5 million… Read More
Listen to today’s podcast!
Researchers believe that an optimistic outlook and a “can-do” attitude could help people – specifically U.S. Hispanics – to stick with a plan for healthy living. This study was completed at Chicago’s Northwestern… Read More
New trial data has shown that liraglutide (sold as Novo Nordisk’s Victoza) can significantly reduce the risk of experiencing a major cardiovascular event. The results came from an international trial following more than 9,300 high-risk… Read More
Listen to today’s podcasts here!
A recent study found that when overweight individuals lost a modest amount of weight over a three-year period, they experienced improvements in their cardiometabolic risk. This study was completed… Read More